Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

Balance Sheet: Liabilities and Stockholders’ Equity 

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Amgen Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Accounts payable 1,590 1,572 1,366 1,421 1,371
Sales deductions 7,271 5,986 5,174 4,801 3,880
Income taxes payable 1,664 1,195 701 828 557
Employee compensation and benefits 1,381 1,099 1,081 1,098 981
Dividends payable 1,205 1,137 1,083 1,018 946
Accrued interest payable 936 470
Other 2,902 2,637 2,692 2,396 2,147
Accrued liabilities 15,359 12,524 10,731 10,141 8,511
Current portion of long-term debt 1,443 1,591 87 91 2,953
Current liabilities 18,392 15,687 12,184 11,653 12,835
Long-term debt, excluding current portion 63,170 37,354 33,222 32,895 26,950
Long-term deferred tax liabilities 2,354 11
Long-term tax liabilities 4,680 5,757 6,594 6,968 8,037
Other noncurrent liabilities 2,326 2,651 2,465 2,023 2,212
Noncurrent liabilities 72,530 45,773 42,281 41,886 37,199
Total liabilities 90,922 61,460 54,465 53,539 50,034
Common stock and additional paid-in capital; $0.0001 par value per share 33,070 32,514 32,096 31,802 31,531
Accumulated deficit (26,549) (28,622) (24,600) (21,408) (21,330)
Accumulated other comprehensive loss (289) (231) (796) (985) (528)
Stockholders’ equity 6,232 3,661 6,700 9,409 9,673
Total liabilities and stockholders’ equity 97,154 65,121 61,165 62,948 59,707

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Amgen Inc. current liabilities increased from 2021 to 2022 and from 2022 to 2023.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Amgen Inc. noncurrent liabilities increased from 2021 to 2022 and from 2022 to 2023.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Amgen Inc. total liabilities increased from 2021 to 2022 and from 2022 to 2023.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Amgen Inc. stockholders’ equity decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.